This paper reviews the literature and institutional experience regarding the surgical management of patients with Chagas disease.
Surgical options for Chagas cardiomyopathy merit review where relevant; leaves open need for prospective outcome data in non-endemic settings.
Although Chagas disease is a rare entity in North America, it is associated with significant cardiac morbidity. It is estimated that 20-30% of those who are infected will eventually develop cardiovascular disease secondary to Chagas disease. We review the literature and share our experience on the surgical management of this challenging patient population.
No takes yet. Share an insight, caveat, or question.
Magarakis et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: